Start › Niedrobnokomórkowy rak płuca › Illinois › Evanston
Badania kliniczne dla Niedrobnokomórkowy rak płuca w mieście Evanston, IL
22 badań dla Niedrobnokomórkowy rak płuca szuka uczestników w ośrodkach w mieście Evanston i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi dalej
- Advocate Lutheran General Hospital, Park Ridge · 8 mi dalej
- i 1 więcej
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekrutacjaFaza 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi dalej
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekrutacjaFaza 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RekrutacjaFaza 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Illinois Cancer Specialists, Niles · 6 mi dalej
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekrutacjaFaza 3
- Illinois Cancer Specialists, Niles · 6 mi dalej
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekrutacjaFaza 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi dalej
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- Illinois Cancer Specialists /ID# 274678, Niles · 6 mi dalej
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekrutacjaFaza 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekrutacjaFaza 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · 6 mi dalej
- Advocate Medical Group Oncology, Park Ridge · 8 mi dalej
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
RekrutacjaBadanie obserwacyjne
- Orchard Healthcare Research Inc., Skokie · 2 mi dalej
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
RekrutacjaFaza 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · 2 mi dalej
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Niles · 6 mi dalej
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekrutacjaFaza 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi dalej
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RekrutacjaFaza 2
- Advocate Aurora Health, Park Ridge · 8 mi dalej
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi dalej
- Advocate Lutheran General Hospital, Park Ridge · 8 mi dalej
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi dalej
- Advocate Lutheran General Hospital, Park Ridge · 8 mi dalej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi dalej
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi dalej
- Advocate Lutheran General Hospital, Park Ridge · 8 mi dalej
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- Advocate Lutheran General Hospital, Park Ridge · 8 mi dalej
GEMINI-NSCLC: NSCLC Biomarker Study
RekrutacjaBadanie obserwacyjne
- Northwestern University, Evanston
Badania dla Niedrobnokomórkowy rak płuca w innych miastach
- Houston, TX145 badań
- New York City, NY120 badań
- Arlington, VA104 badań
- Nashville, TN97 badań
- Boston, MA90 badań
- Los Angeles, CA87 badań
- St. Louis, MO73 badań
- Chicago, IL61 badań
- Baltimore, MD60 badań
- San Antonio, TX59 badań
- Columbus, OH56 badań
- Washington, DC55 badań
Inne badania w mieście Evanston
- Rak płuc19 badań
- Rak piersi13 badań
- Ostra białaczka szpikowa11 badań
- Otyłość11 badań
- Rak jelita grubego i odbytnicy10 badań
- Nowotwory (wszystkie typy)9 badań
- Nadwaga9 badań
- Wrzodziejące zapalenie jelita grubego9 badań
- Rak prostaty9 badań
- Choroba Leśniowskiego-Crohna9 badań
- Niewydolność serca8 badań
- Migotanie przedsionków8 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.